The current evidence suggests that there is an imbalance in the RAS following stroke with an enhanced activation of the ACE/Ang II/AT1R pathway and that targeting the counter-regulatory ACE2/Ang-(1–7)/Mas axis may provide protection. Here, ACE2 is linked to Stroke.